摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

10-Oxo-1,5-diaza-bicyclo<4.4.0>dec-5-en | 1784-72-1

中文名称
——
中文别名
——
英文名称
10-Oxo-1,5-diaza-bicyclo<4.4.0>dec-5-en
英文别名
2,3,4,7,8,9-hexahydro-pyrido[1,2-a]pyrimidin-6-one;1,5-Diazabicyclo[4.4.0]dec-5-en-10-one;2,3,4,7,8,9-hexahydropyrido[1,2-a]pyrimidin-6-one
10-Oxo-1,5-diaza-bicyclo<4.4.0>dec-5-en化学式
CAS
1784-72-1
化学式
C8H12N2O
mdl
——
分子量
152.196
InChiKey
SENZWMNCHJFUGV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    32.7
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • METHOD FOR PRODUCING 3-SUBSTITUTED-4-FLUOROPYRROLIDINE DERIVATIVE
    申请人:Suzuki Masashi
    公开号:US20130085282A1
    公开(公告)日:2013-04-04
    An inexpensive and industrially advantageous method for producing optically active syn-3-(N-substituted-aminomethyl)-4-fluoropyrrolidine which may be an intermediate for producing pharmaceuticals is provided. The present invention relates a method for producing a syn-1-protected-4-fluoro-3-(N-substituted-N-nitrobenzenesulfonyl)pyrrolidine derivative or it's enantiomer, or their salts comprising the process of fluorinating a compound represented by the general formula (6) (in the formula, PG 1 represents a protecting group for an amino group, R 1 represents a C1 to C6 alkyl group which may be substituted or a C3 to C8 cycloalkyl group which may be substituted, and Ns represents a 2-nitrobenzenesulfonyl group or a 4-nitrobenzenesulfonyl group) or it's enantiomer using a nucleophilic fluorinating agent and an organic base having an amidine or guanidine structure.
    提供了一种廉价且工业上优势的方法,用于生产光学活性的syn-3-(N-取代甲基)-4-吡咯烷,该化合物可能是生产药物的中间体。本发明涉及一种生产syn-1-保护的-4--3-(N-取代-N-硝基苯磺酰基)吡咯烷衍生物或其对映体或其盐的方法,包括将通式(6)所代表的化合物(其中,PG1代表基的保护基,R1代表可取代的C1到C6烷基或可取代的C3到C8环烷基,Ns代表2-硝基苯磺酰基或4-硝基苯磺酰基)或其对映体使用亲核化试剂和具有酰胺或鸟嘌呤结构的有机碱进行化的过程。
  • Curable composition, image forming material, and planographic printing plate precursor
    申请人:FUJIFILM Corporation
    公开号:EP2042522A1
    公开(公告)日:2009-04-01
    A curable composition in which polymerization inhibition due to oxygen is suppressed and which may be cured with high sensitivity by exposure to laser light or the like is provided. The curable composition includes: a polymerizable compound having an ethylenically unsaturated bond; a binder; a radical polymerization initiator; and at least one specific amine compound. Also provided is an image forming material and a negative-working planographic printing plate precursor including the curable composition.
    本发明提供了一种可固化组合物,该组合物抑制了氧气引起的聚合抑制,并可通过激光或类似光源进行高灵敏度固化。这种可固化组合物包括:具有乙烯不饱和键的可聚合化合物;粘合剂;自由基聚合引发剂;以及至少一种特定的胺化合物。此外,还提供了一种图像形成材料和一种包括该可固化组合物的底片-工作平版印刷板前体。
  • PROCESS FOR PREPARATION OF 3-SUBSTITUTED-4-FLUOROPYRROLIDINE DERIVATIVES
    申请人:Kyorin Pharmaceutical Co., Ltd.
    公开号:EP2578568A1
    公开(公告)日:2013-04-10
    An inexpensive and industrially advantageous method for producing optically active syn-3-(N-substituted-aminomethyl)-4-fluoropyrrolidine which may be an intermediate for producing pharmaceuticals is provided. The present invention relates a method for producing a syn-1-protected-4-fluoro-3-(N-substituted-N-nitrobenzenesulfonyl)pyrrolidine derivative or it's enantiomer, or their salts comprising the process of fluorinating a compound represented by the general formula (6) (in the formula, PG1 represents a protecting group for an amino group, R1 represents a C1 to C6 alkyl group which may be substituted or a C3 to C8 cycloalkyl group which may be substituted, and Ns represents a 2-nitrobenzenesulfonyl group or a 4-nitrobenzenesulfonyl group) or it's enantiomer using a nucleophilic fluorinating agent and an organic base having an amidine or guanidine structure.
    本发明提供了一种生产具有光学活性的合成-3-(N-取代-甲基)-4-吡咯烷的廉价且具有工业优势的方法,该方法可作为生产药物的中间体。本发明涉及一种生产受 syn-1 保护的-4--3-(N-取代-N-硝基苯磺酰基)吡咯烷衍生物或其对映体或它们的盐的方法,包括将通式 (6) 所代表的化合物化的过程(式中,PG1 代表基的保护基团、R1 代表可能被取代的 C1 至 C6 烷基或可能被取代的 C3 至 C8 环烷基,Ns 代表 2-硝基苯磺酰基或 4-硝基苯磺酰基)或其对映体,使用亲核化剂和具有脒基或基结构的有机碱。
  • AMIDO COMPOUNDS AS RORYT MODULATORS AND USES THEREOF
    申请人:New York University
    公开号:EP3002008A1
    公开(公告)日:2016-04-06
    Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R1a, R1b, R2, R3, R4, R5, and R6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.
    本发明公开了具有下式表示的氨基化合物: 其中 n1、n2、R1a、R1b、R2、R3、R4、R5 和 R6 如本文所述。这些化合物可制备成药物组合物,并可用于预防和治疗包括人类在内的哺乳动物的各种疾病,包括非限制性的炎症、自身免疫性疾病、癌症和移植物抗宿主疾病。
  • Amido compounds as RORγt modulators and uses thereof
    申请人:New York University
    公开号:US10561666B2
    公开(公告)日:2020-02-18
    Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R1a, R1b, R2, R3, R4, R5, and R6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.
    本发明公开了具有下式表示的氨基化合物: 其中 n1、n2、R1a、R1b、R2、R3、R4、R5 和 R6 如本文所述。这些化合物可制备成药物组合物,并可用于预防和治疗包括人类在内的哺乳动物的各种疾病,包括非限制性的炎症、自身免疫性疾病、癌症和移植物抗宿主疾病。
查看更多

同类化合物

阿昔替酯 螺喹唑啉 苯并[g][1,2,3]三唑并[4',5':5,6]吡啶并[2,1-b]喹唑啉-13(2H)-酮 脱氢利培酮 盐酸曲林菌素 甲硫利马唑 甲基8-乙基-2-甲氧基-5-氧代-5,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基8-乙基-2-(甲硫基)-5-氧代-5,6,7,8-四氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基2-乙氧基-8-乙基-5-氧代-吡啶并[6,5-d]嘧啶-6-羧酸酯 溴他替尼 泮托拉唑杂质DF 氨甲酸,[(2R,3E)-2-羟基-3-戊烯基]-,1,1-二甲基乙基酯(9CI) 柱孢藻毒素 曲美替尼 曲美替尼 曲喹辛 异噻唑并[5,4-d]嘧啶,3-亚硝基-(9CI) 帕潘立酮棕榈酸酯 帕潘立酮杂质7 帕潘立酮杂质16 帕潘立酮杂质 帕潘立酮杂质 帕潘立酮去氟杂质 帕潘立酮Z-异构体 帕潘立酮 帕泊昔布杂质117 帕布昔利布杂质46 帕博西尼杂质S 帕利哌酮杂质05 帕利哌酮杂质03 帕利哌酮杂质02 帕利哌酮十四酸酯 帕利哌酮N-氧化物 布喹特林 巴马斯汀 奥卡哌酮 多夸司特 嘧啶并[4,5-d]嘧啶-2,4,5(1H,3H,6H)-三酮,7-乙氧基-1,3-二甲基-6-(苯基甲基)- 吡曲克辛 吡嘧司特钾 吡嘧司特 吡啶并[4,3-d]嘧啶-4(1H)-酮,4,5,6,7-四氢-6-甲基-2-苯基- 吡啶并[4,3-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,2-d]嘧啶-4(3H)-酮,3-甲基-2-(甲基氨基)- 吡啶并[3,2-d]嘧啶-4(3H)-酮 吡啶并[3,2-d]嘧啶-4(1H)-酮,2,3-二氢-3-(2-羟基苯基)-2-硫代- 吡啶并[3,2-d]嘧啶-2,4(1H,3H)-二酮 吡啶并[2,3-d]嘧啶-7(8h)-酮,2,6-二溴-8-环戊基-5-甲基- 吡啶并[2,3-d]嘧啶-7(8H)-酮